Pfizer and BioNTech will apply for emergency use authorization for their COVID-19 vaccine from the Food and Drug Administration Friday, making it the first coronavirus vaccine to be considered for widespread use.
“Pfizer’s partner BioNTech has announced that tomorrow, they intend to file for emergency use authorization at the FDA,” Health and Human Services Secretary Alex Azar said Thursday.
Real journalism.Trusted by millions.
Unlimited access to in-depth reporting, expert analysis, and the stories that shape our country.
Subscribe Now
Already a member? Log in
Print subscriber? Click here to login/register your account
Digital subscriber? Click here to login/register your account.